@ARTICLE{
author={Pastores Gregory M,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Szer Jeffrey,Deegan Patrick B,Amato Dominick J,Mengel Eugen,Tan Ee Shien,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2014},
title={A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={53},
number={4},
pages={253-260},
document_type={Article},
} 

@ARTICLE{
author={Biegstraaten Marieke,Mengel Eugen,Marodi Laszlo,Petakov Milan S,Niederau Claus,Giraldo Pilar,Hughes Derralyn,Mrsic Mirando,Mehta Atul,Hollak Carla EM,van Schaik Ivo N},
year={2010},
title={Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study},
journal={BRAIN},
volume={133},
number={},
pages={2909-2919},
document_type={Article},
}